Monthly Round-Up of What to Read on Pharma Law and Policy
Bill of Health
OCTOBER 7, 2022
New Reforms to Prescription Drug Pricing in the US: Opportunities and Challenges. US Food and Drug Administration Approval of High-risk Cardiovascular Devices for Use in Children and Adolescents, 1977-2021. Reforming Patient Cost Sharing for Cancer Medications in Medicare Part D. JAMA Oncol. 2022 Aug 4.
Let's personalize your content